PolyPid (PYPD) Competitors $3.41 +0.05 (+1.49%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$3.40 -0.01 (-0.15%) As of 08/1/2025 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYPD vs. LAKE, LUNG, BSGM, OBIO, INFU, LUCD, AVR, MBOT, ICAD, and ZJYLShould you be buying PolyPid stock or one of its competitors? The main competitors of PolyPid include Lakeland Industries (LAKE), Pulmonx (LUNG), Biosig Technologies (BSGM), Orchestra BioMed (OBIO), InfuSystem (INFU), Lucid Diagnostics (LUCD), Anteris Technologies Global (AVR), Microbot Medical (MBOT), icad (ICAD), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. PolyPid vs. Its Competitors Lakeland Industries Pulmonx Biosig Technologies Orchestra BioMed InfuSystem Lucid Diagnostics Anteris Technologies Global Microbot Medical icad Jin Medical International Lakeland Industries (NASDAQ:LAKE) and PolyPid (NASDAQ:PYPD) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Is LAKE or PYPD more profitable? PolyPid has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.31%. Lakeland Industries' return on equity of -6.88% beat PolyPid's return on equity.Company Net Margins Return on Equity Return on Assets Lakeland Industries-13.31% -6.88% -4.47% PolyPid N/A -1,069.37%-151.85% Do analysts rate LAKE or PYPD? Lakeland Industries currently has a consensus price target of $26.00, suggesting a potential upside of 94.76%. PolyPid has a consensus price target of $11.80, suggesting a potential upside of 246.04%. Given PolyPid's stronger consensus rating and higher probable upside, analysts plainly believe PolyPid is more favorable than Lakeland Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lakeland Industries 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00PolyPid 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Does the media refer more to LAKE or PYPD? In the previous week, Lakeland Industries and Lakeland Industries both had 1 articles in the media. Lakeland Industries' average media sentiment score of 0.00 equaled PolyPid'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lakeland Industries 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PolyPid 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, LAKE or PYPD? Lakeland Industries has higher revenue and earnings than PolyPid. Lakeland Industries is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeland Industries$177.65M0.72-$18.08M-$3.01-4.44PolyPidN/AN/A-$29.02M-$4.30-0.79 Which has more risk & volatility, LAKE or PYPD? Lakeland Industries has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, PolyPid has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Do insiders and institutionals have more ownership in LAKE or PYPD? 71.7% of Lakeland Industries shares are held by institutional investors. Comparatively, 26.5% of PolyPid shares are held by institutional investors. 1.9% of Lakeland Industries shares are held by insiders. Comparatively, 24.7% of PolyPid shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryPolyPid beats Lakeland Industries on 8 of the 14 factors compared between the two stocks. Get PolyPid News Delivered to You Automatically Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYPD vs. The Competition Export to ExcelMetricPolyPidMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.24M$2.51B$5.49B$9.54BDividend YieldN/A1.81%4.73%4.09%P/E Ratio-0.798.9728.8623.83Price / SalesN/A434.56371.4866.02Price / CashN/A157.7635.4557.96Price / Book4.554.838.275.54Net Income-$29.02M$31.62M$3.25B$259.28M7 Day Performance-7.34%-5.28%-3.73%-4.68%1 Month Performance-2.29%4.38%4.29%4.36%1 Year Performance-3.40%-2.49%25.87%17.89% PolyPid Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYPDPolyPid2.2803 of 5 stars$3.41+1.5%$11.80+246.0%-6.6%$34.24MN/A-0.7980LAKELakeland Industries4.4608 of 5 stars$14.74-1.5%$26.00+76.4%-42.8%$142.34M$167.21M-4.902,100LUNGPulmonx3.8397 of 5 stars$3.09-7.5%$11.53+273.0%-75.2%$134.46M$87.47M-2.15250Trending NewsEarnings ReportAnalyst ForecastBSGMBiosig Technologies2.0798 of 5 stars$4.57-4.6%$10.00+118.8%+972.2%$130.74M$40K0.0050Gap DownOBIOOrchestra BioMed2.4413 of 5 stars$3.40+3.3%$14.00+311.8%-64.4%$130.26M$2.89M-1.914News CoverageGap DownINFUInfuSystem2.8593 of 5 stars$5.90-1.8%$12.50+111.9%N/A$126.31M$137.58M98.35410LUCDLucid Diagnostics2.728 of 5 stars$1.09-1.8%$3.55+225.7%+25.0%$120.09M$4.35M-0.8170AVRAnteris Technologies GlobalN/A$3.35+3.1%$16.50+392.5%N/A$117.20M$2.70M0.00138MBOTMicrobot Medical1.8316 of 5 stars$2.90-2.4%$9.00+210.3%+162.2%$108.04MN/A-4.4620News CoverageOptions VolumeGap UpHigh Trading VolumeICADicad0.901 of 5 stars$3.87flatN/AN/A$106.31M$19.61M-20.37140Positive NewsZJYLJin Medical InternationalN/A$0.66+2.0%N/A-76.3%$101.54M$23.50M0.00245News CoverageGap Down Related Companies and Tools Related Companies Lakeland Industries Alternatives Pulmonx Alternatives Biosig Technologies Alternatives Orchestra BioMed Alternatives InfuSystem Alternatives Lucid Diagnostics Alternatives Anteris Technologies Global Alternatives Microbot Medical Alternatives icad Alternatives Jin Medical International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYPD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PolyPid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
